Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials
Carolyn Williamson(National Health Laboratory Service), James I. Mullins(University of Washington), James P. Ludwig, Michal Juraska(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lennie Chen(University of Washington), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Anna Yssel(University of Cape Town), Bronwen E. Lambson(National Health Laboratory Service), Roger E. Bumgarner(Texas Biomedical Research Institute), Srilatha Edupuganti(Emory University), Raabya Rossenkhan(Fred Hutch Cancer Center), Nonkululeko Ndabambi(University of Cape Town), Myron S. Cohen(University of North Carolina at Chapel Hill), Paula Marantz Cohen(University of Cape Town), Talita York(University of Cape Town), Dylan H. Westfall(University of Washington), Penny L. Moore(University of the Witwatersrand), Paul T. Edlefsen(Fred Hutch Cancer Center), Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Craig A. Magaret(Fred Hutch Cancer Center), Ben Murrell(Karolinska Institutet), Nonhlanhla N. Mkhize(Respiratory and Meningeal Pathogens Research Unit), Wenjie Deng(University of Washington), David Matten(University of Cape Town), Lynn Morris(National Health Laboratory Service), Chivonne Moodley(University of Cape Town), Tanmoy Bhattacharya(Los Alamos National Laboratory), Nicolas Beaume(University of Cape Town), Lawrence Corey(Fred Hutch Cancer Center), Alec Pankow(Karolinska Institutet), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Bryan T. Mayer(Fred Hutch Cancer Center), Morgane Rolland(Henry M. Jackson Foundation), Ruwayhida Thebus(University of Cape Town), Haajira Kaldine(National Health Laboratory Service), M. Juliana McElrath(Fred Hutch Cancer Center), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Elena E. Giorgi(Fred Hutch Cancer Center), Daniel B. Reeves(Fred Hutch Cancer Center), Hongjun Bai(Henry M. Jackson Foundation), Asanda Gwashu-Nyangiwe(University of Cape Town), Hong Zhao(University of Washington), Lily Zhang(Fred Hutch Cancer Center), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Cindy Molitor(Fred Hutch Cancer Center), David C. Montefiori(Duke University), Sinethemba Bhebhe(National Center for Communicable Diseases), Nyaradzo Mgodi(University of Zimbabwe)
Cited by 1
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k